Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects

Identification and in Vivo and in Vitro Characterization of Long Acting and Melanocortin 4 Receptor (MC4-R) Selective α-Melanocyte-Stimulating Hormone (α-MSH) Analogues

(2012) Kilian Conde-Frieboes et al.   JOURNAL OF MEDICINAL CHEMISTRY

An eruptive pigmented lesion after melanotan injection

(2011) C. Ferrándiz-Pulido et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Melatonin Used for Tanning Induces and Augments Lentigines and Naevi

(2010) K Thestrup-Pedersen et al.   ACTA DERMATO-VENEREOLOGICA

Acral Melanocytic Nevi: Prevalence and Distribution of Gross Morphologic Features in White and Black Adults

(2010) G. A. Palicka et al.   ARCHIVES OF DERMATOLOGY

Standards of Medical Care in Diabetes--2011

(2010)   DIABETES CARE

Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy

(2009) R Krishna et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Lack of Erectogenic Activity of a Novel Selective Melanocortin-4 Receptor Agonist in a Clinical Experimental Model

(2008) Rajesh Krishna et al.   JOURNAL OF CLINICAL PHARMACOLOGY

RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study

(2008) Mohammad Reza Safarinejad   Journal of Sexual Medicine

Modulation of Blood Pressure by Central Melanocortinergic Pathways

(2008) Jerry R. Greenfield et al.   NEW ENGLAND JOURNAL OF MEDICINE